TY - JOUR
T1 - Improved Cardiovascular Disease Outcomes in Older Adults
AU - Forman, Daniel E.
AU - Alexander, Karen
AU - Brindis, Ralph G.
AU - Curtis, Anne B.
AU - Maurer, Mathew
AU - Rich, Michael W.
AU - Sperling, Laurence
AU - Wenger, Nanette K.
N1 - Publisher Copyright:
© 2016 Forman DE et al.
PY - 2016
Y1 - 2016
N2 - Longevity is increasing and the population of older adults is growing. The biology of aging is conducive to cardiovascular disease (CVD), such that prevalence of coronary artery disease, heart failure, valvular heart disease, arrhythmia and other disorders are increasing as more adults survive into old age. Furthermore, CVD in older adults is distinctive, with management issues predictably complicated by multimorbidity, polypharmacy, frailty and other complexities of care that increase management risks (e.g., bleeding, falls, and rehospitalization) and uncertainty of outcomes. In this review, state-of-the-art advances in heart failure, acute coronary syndromes, transcatheter aortic valve replacement, atrial fibrillation, amyloidosis, and CVD prevention are discussed. Conceptual benefits of treatments are considered in relation to the challenges and ambiguities inherent in their application to older patients.
AB - Longevity is increasing and the population of older adults is growing. The biology of aging is conducive to cardiovascular disease (CVD), such that prevalence of coronary artery disease, heart failure, valvular heart disease, arrhythmia and other disorders are increasing as more adults survive into old age. Furthermore, CVD in older adults is distinctive, with management issues predictably complicated by multimorbidity, polypharmacy, frailty and other complexities of care that increase management risks (e.g., bleeding, falls, and rehospitalization) and uncertainty of outcomes. In this review, state-of-the-art advances in heart failure, acute coronary syndromes, transcatheter aortic valve replacement, atrial fibrillation, amyloidosis, and CVD prevention are discussed. Conceptual benefits of treatments are considered in relation to the challenges and ambiguities inherent in their application to older patients.
UR - http://www.scopus.com/inward/record.url?scp=84964495049&partnerID=8YFLogxK
U2 - 10.12688/f1000research.7088.1
DO - 10.12688/f1000research.7088.1
M3 - Review article
C2 - 26918183
AN - SCOPUS:84964495049
SN - 2046-1402
VL - 5
JO - F1000Research
JF - F1000Research
M1 - 112
ER -